Avidity Biosciences
139 hedge funds and large institutions have $1.17B invested in Avidity Biosciences in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 78 increasing their positions, 25 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 148 → 139 (-9)
26% less capital invested
Capital invested by funds: $1.57B → $1.17B (-$404M)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
Holders
139
Holding in Top 10
4
Calls
$2.85M
Puts
$180K
Top Buyers
| 1 | +$14.8M | |
| 2 | +$12.4M | |
| 3 | +$12M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$9.28M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$8.74M |
Top Sellers
| 1 | -$30.8M | |
| 2 | -$16.7M | |
| 3 | -$10.2M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.88M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$6.66M |